AXA SA Q2 2026 Earnings Recap

AXA shares edged down 0.6% post-earnings as the market appeared cautious despite stable margins and positive growth; modest pressures from Middle East losses and cautious forward commentary likely weighed on sentiment.

Key Takeaways

• Reported 5% organic top-line growth and 8% underlying EPS growth, nearing the upper end of the company’s 6-8% target range.
• P&C combined ratio stable at 90.1%, though up 30 bps excluding the Prima portfolio due to EUR 0.1 billion losses from AXA XL in the Middle East.
• AXA XL technical margin excluding Middle East impact was stable, with pricing holding up better than the market amid cycle challenges.
• Investment income increased, driven by higher reinvestment yields and asset reallocation to private debt, offsetting unwind increases.
• Life & Health premiums grew 8% with 11% earnings growth, supported by strong performance in both short-term and long-term businesses.